Because genetic EC-S1pr2 deficiency can enhance angiogenesis and improve blood flow recovery after ischemia, we next tested whether pharmacological inhibition of S1pr2 had a beneficial effect on hindlimb ischemia. Here, S1PR2 is linked to ischemia.